Patents Assigned to Molecular Diagnostics, Inc.
-
Patent number: 6663576Abstract: A system for accurately obtaining cervical cells from a patient and quickly screening the sample includes a collector for collecting a spatially arranged cell sample from a target tissue, and an analyzer that examines the cell sample for abnormal cells while the cell sample remains on a surface of the collector.Type: GrantFiled: November 29, 2000Date of Patent: December 16, 2003Assignee: Molecular Diagnostics, Inc.Inventors: Peter P. Gombrich, Richard A. Domanik, George Gorodeski
-
Publication number: 20020106718Abstract: Cellular samples such as cervical cells can be obtained from a cell suspension and then transferred to a microscope slide for analysis. The cells can be retrieved from the cell suspension using an inexpensive, easy to use device that requires no instruments or ancillary devices, minimal operator skill and training, and is potentially sufficiently low cost that it is suitable for use in mass screening programs.Type: ApplicationFiled: December 4, 2001Publication date: August 8, 2002Applicant: MOLECULAR DIAGNOSTICS, INC.Inventors: Peter P. Gombrich, Richard A. Domanik
-
Publication number: 20020085744Abstract: An effective and convenient means exists for registering and correlating two or more microscopic images without imposing unusually stringent requirements of accuracy, precision and resolution on the microscope system. Particular utility is found in examining cervical cell samples.Type: ApplicationFiled: November 19, 2001Publication date: July 4, 2002Applicant: MOLECULAR DIAGNOSTICS, INC.Inventors: Richard A. Domanik, L. Nicolas Bernier
-
Publication number: 20020087096Abstract: A cervical cell collection device can easily and comfortably be used by a woman in the privacy and comfort of her own home. Once the woman obtains the cervical cell sample, she can be forward it to a physician's office or other lab location for analysis. The collection device includes an outer guide assembly and an inner sampling assembly bearing a collector.Type: ApplicationFiled: February 11, 2002Publication date: July 4, 2002Applicant: MOLECULAR DIAGNOSTICS, INC.Inventors: David M. Anderson, Peter P. Gombrich, Richard A. Domanik
-
Patent number: 5981700Abstract: Pancreatic islet cell antigens (ICA) that bind with antibodies found in the sera of patients afflicted with insulin-dependent (Type I) diabetes mellitus (IDDM). ICA proteins are expressed by recombinant cloning vehicles comprising DNA inserts isolated from islet cells. Full sequence native ICA proteins, or protein or peptide fragments thereof, can be used in the diagnosis of IDDM and in detecting or blocking human immunoglobulin, T-cells, or B-cells involved in IDDM.Type: GrantFiled: June 6, 1995Date of Patent: November 9, 1999Assignee: Bayer Corporation Formerly Molecular Diagnostics, Inc.Inventor: Daniel U. Rabin
-
Patent number: 5955345Abstract: Pancreatic islet cell antigens (ICA) that bind with antibodies found in the sera of patients afflicted with insulin-dependent (Type I) diabetes mellitus (IDDM). ICA proteins are expressed by recombinant cloning vehicles comprising DNA inserts isolated from islet cells. Full sequence native ICA proteins, or protein or peptide fragments thereof, can be used in the diagnosis of IDDM and in detecting or blocking human immunoglobulin, T-cells, or B-cells involved in IDDM.Type: GrantFiled: June 6, 1995Date of Patent: September 21, 1999Assignee: Bayer Corporation Formerly Molecular Diagnostics Inc.Inventor: Daniel U. Rabin
-
Patent number: 5843761Abstract: A nucleic acid comprising a base sequence which codes for a CEA peptide sequence or nucleic acids having a base sequence hybridizable therewith, replicable recombinant cloning vehicles having an insert comprising such nucleic acid, cells transfected, infected or infected with such cloning vehicles, polypeptides expressed by such cells, antibody preparations specific for such polypeptides, immunoassays for detecting CEA using such antibody preparations and nucleic acid hybridization methods for detecting a CEA nucleic acid sequence using a nucleic acid probe comprising the above described nucleic acid.Type: GrantFiled: June 6, 1995Date of Patent: December 1, 1998Assignee: Bayer Corporation (Formerly Molecular Diagnostics, Inc.)Inventors: Thomas R. Barnett, James J. Elting, Michael E. Kamarck
-
Patent number: 5274087Abstract: Nucleic acid sequences are disclosed that encode carcinoembryonic antigens (CEAs) as are replicable recombinant cloning vehicles containing DNA that encodes CEA proteins.Type: GrantFiled: April 29, 1992Date of Patent: December 28, 1993Assignee: Molecular Diagnostics, Inc.Inventors: Thomas R. Barnett, James J. Elting, Michael E. Kamarck
-
Patent number: 5231009Abstract: A nucleic acid comprising a base sequence which codes for a CEA family member peptide sequence or nucleic acids having a base sequence hybridizable therewith, replicable recombinant cloning vehicles having an insert comprising such nucleic acid, cells transfected, infected or injected with such cloning vehicles, polypeptides expressed by such cells, synthetic peptides derived from the coding sequence of CEA family member nucleic acids, antibody preparations specific for such polypeptides, immunoassays for detecting CEA family members using such antibody preparations and nucleic acid hybridization methods for detecting CEA family member nucleic acid sequences using a nucleic acid probe comprising the above described nucleic acid.Type: GrantFiled: September 13, 1991Date of Patent: July 27, 1993Assignee: Molecular Diagnostics, Inc.Inventors: Thomas R. Barnett, James J. Elting, Michael E. Kamarck, Axel W. Kretschmer
-
Patent number: 5225354Abstract: Monoclonal antibodies specific for the glycosylated lysine residue at position 525 in glycoalbumin and a method for producing such antibodies. The monoclonal antibodies are useful as reagents in immunoassays for the specific determination of glycoalbumin in human blood samples which is indicative of the severity of the diabetic condition. The monoclonal antibodies are secreted by hybridomas obtained by fusing a myeloma cell with a lymphocyte that has been taken from an animal, usually a mouse, immunized with a peptide immunogen and which produces antibody to the lysine 525 residue in glycoalbumin. The synthetic peptide immunogen comprises a peptide residue which includes an .epsilon.-amino glucosylated lysine and an adjacent amino acid sequence in which at least one of the amino acid units is in a position corresponding to the peptide sequence of human albumin adjacent to lysine 525, the glycosylated peptide residue being linked to an immunogenic carrier.Type: GrantFiled: August 21, 1992Date of Patent: July 6, 1993Assignee: Molecular Diagnostics, Inc.Inventors: William J. Knowles, Vincent T. Marchesi
-
Patent number: 5122599Abstract: This invention relates to a nucleic acid comprising a base sequence which codes for a CEA family member peptide sequence or nucleic acids having a base sequence hybridizable therewith, replicable recombinant cloning vehicles having an insert comprising such nucleic acid, cells transfected, infected or injected with such cloning vehicles, polypeptides expressed by such cells, synthetic peptides derived from the coding sequence of CEA family member nucleic acids, antibody preparations specific for such polypeptides, immunoassays for detecting CEA family members using such antibody preparations and nucleic acid hybridization methods for detecting CEA family member nucleic acid sequences using a nucleic acid probe comprising the above described nucleic acid.Type: GrantFiled: November 21, 1988Date of Patent: June 16, 1992Assignee: Molecular Diagnostics, Inc.Inventors: Thomas R. Barnett, James J. Elting, Michael E. Kamarck, Axel W. Kretschmer
-
Patent number: 5061790Abstract: A method for conferring or increasing the antigenicity of a disulfide-crosslinked protein by treating the protein with an oxidizing agent, such as periodate, having an oxidation potential sufficient to cleave disulfide linkages. Excess oxidizing agent is then inactivated by addition of a reducing agent. The resulting protein exhibits an increase in its ability to be bound by select antibodies, particularly monoclonal antibodies directed to linear peptide epitopes in the protein.Type: GrantFiled: July 10, 1989Date of Patent: October 29, 1991Assignee: Molecular Diagnostics, Inc.Inventors: James J. Elting, Heinz Kolbl
-
Patent number: 5026840Abstract: A photochemical nucleic acid-labeling reagent of the formula ##STR1## wherein Q is a photoreactive residue of a nucleic acid-binding ligand; L is a detectable label residue; R is hydrogen, C.sub.1 to C.sub.7 -alkyl, aryl, hydroxy, or C.sub.1 to C.sub.7 -alkoxy; x is an integer from 2 through 7; and Y is an integer from 3 through 10; wherein R and x, respectively, can be the same or different each time they appear in the formula. The reagent is useful in the highly efficient labeling of nucleic acids for the purpose of detection in hybridization assays.Type: GrantFiled: February 6, 1990Date of Patent: June 25, 1991Assignee: Molecular Diagnostics, Inc.Inventors: Nanibhushan Dattagupta, James P. Albarella
-
Patent number: 4968602Abstract: A process for determining the presence of a particular nucleic acid sequence in a test sample comprising(a) chemically modifying nucleic acids in the test sample either to introduce a label or a reactive site in a manner that supports their hybridizability,(b) contacting under hybridization conditions the chemically modified sample nucleic acids with a hybridizable nucleic acid probe which either, when the sample nucleic acids have been modified to introduce a label, carrys a reactive site or, when the sample nucleic acids have been modified to introduce a reactive site, is labeled,(c) contacting the solution resulting from step (b) with a immobilized form of a reactive partner to the reactive site to form a stable bond with the reactive site on the sample nucleic acids or the probe, respectively,(d) separating the resulting immobilized fraction from the remaining solution, and(e) determining the presence of the label in the separated immobilized fraction or a decrease in the label in the remaining solution.Type: GrantFiled: November 21, 1989Date of Patent: November 6, 1990Assignee: Molecular Diagnostics, Inc.Inventor: Nanibhushan Dattagupta
-
Patent number: 4959309Abstract: A labeled nucleic acid probe comprising (a) a nucleic acid component, (b) a nucleic acid-binding ligand photochemically linked to the nucleic acid component, and (c) a label chemically linked to the nucleic acid-binding ligand. The label can be a specifically bindable ligand such as a hapten or biotin, an enzyme such as a .beta.-galactosidase or horse radish peroxidase, a fluorescent radical, a phycobiliprotein, a luminescent radical, or a radioisotope. The probe can be used in assays of nucleic acids, taking advantage of the ability of the nucleic acid component to hydridize.Type: GrantFiled: October 9, 1987Date of Patent: September 25, 1990Assignee: Molecular Diagnostics, Inc.Inventors: Nanibhushan Dattagupta, Donald M. Crothers
-
Patent number: 4950588Abstract: A chemiluminescence process comprising the contacting of a chemiluminescence precursor, an oxidant, an enzyme, a chemiluminescence enhancer and a nitrogen compound selected from the group consisting of ammonia and water-soluble organic amines. The reaction of such process can be used in detection of nucleic acid hybrids, antibodies, antigens and peroxidase enzymes and in producing light.Type: GrantFiled: September 27, 1988Date of Patent: August 21, 1990Assignee: Molecular Diagnostics, Inc.Inventor: Nanibhushan Dattagupta
-
Patent number: 4950744Abstract: A photochemical nucleic acid-labeling reagent of the formula ##STR1## wherein Q is a photoreactive residue of a nucleic acid-binding ligand; L is a detectable label residue; R is hydrogen, C.sub.1 to C.sub.7 -alkyl, aryl, hydroxy, or C.sub.1 to C.sub.7 -alkoxy; x is an integer from 2 through 7; and y is an integer from 3 through 10; wherein R and x, respectively, can be the same or different each time they appear in the formula. The reagent is useful in the highly efficient labeling of nucleic acids for the purpose of detection in hybridization assays.Type: GrantFiled: March 18, 1987Date of Patent: August 21, 1990Assignee: Molecular Diagnostics, Inc.Inventors: Nanibhushan Dattagupta, James P. Albarella
-
Patent number: 4853327Abstract: A chemiluminescence process comprising the contacting of a chemiluminescence precursor, an oxidant, an enzyme and a nitrogen compound selected from the group consisting of ammonia and a water-soluble organic amine. The reaction of such process can be used in detection of nucleic acid hybrids, antibodies, antigens and peroxidase enzymes and in producing light.Type: GrantFiled: July 10, 1985Date of Patent: August 1, 1989Assignee: Molecular Diagnostics, Inc.Inventor: Nanibhushan Dattagupta
-
Patent number: 4824775Abstract: In passing labeled cells through a cell sorter, the improvement which comprises employing a labeled cell comprising a cell, an antibody specific to and bound to such cell, a nucleic acid fragment joined to said antibody, and a plurality of labels on said nucleic acid fragment. Because of the presence of multiple labels, the sensitivity of the separation of labeled cells is increased.Type: GrantFiled: January 3, 1985Date of Patent: April 25, 1989Assignee: Molecular Diagnostics, Inc.Inventors: Nanibhushan Dattagupta, Michael E. Kamarck
-
Patent number: 4818681Abstract: A process for synthesizing an oligonucleotide comprising linking a nucleoside phosphate to a solid support, through the heterocyclic moiety of the nucleoside, coupling a mono- or oligonucleotide to the nucleoside phosphate through its phosphate moiety, in at least one step enzymatically lengthening the mono- or oligonucleotide, cleaving the resultant oligonucleotide from the solid support-nucleoside phosphate at the phosphate moiety of the nucleoside, and separating the oligonucleotide. After cleaving and separating the solid support-nucleoside phosphate is recycled for further coupling. Advantageously the solid support-nucleoside phosphate is phosphorylated between separation and recycling.Type: GrantFiled: February 22, 1985Date of Patent: April 4, 1989Assignee: Molecular Diagnostics, Inc.Inventor: Nanibhushan Dattagupta